MedPath

Diphtheria/Tetanus Toxoid combined vaccine (Seqirus)

Generic Name
Diphtheria/Tetanus Toxoid combined vaccine (Seqirus)

Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder

Phase 2
Completed
Conditions
Major Depressive Disorder
Interventions
First Posted Date
2010-01-20
Last Posted Date
2015-11-01
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Target Recruit Count
773
Registration Number
NCT01052077
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

Southwestern Research, Beverly Hills, California, United States

🇺🇸

California Neuroscience Research Medical Group, Inc., Sherman Oaks, California, United States

and more 39 locations

Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Phase 2
Completed
Conditions
Major Depressive Disorder
Interventions
First Posted Date
2008-11-25
Last Posted Date
2016-02-29
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Target Recruit Count
850
Registration Number
NCT00797966
Locations
🇺🇸

Florida Clinical Research Center, LLC, Bradenton, Florida, United States

🇺🇸

Vince & Associates Clinical Research, Overland Park, Kansas, United States

🇺🇸

Synergy Clinical Research Center, National City, California, United States

and more 47 locations

Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer

Phase 2
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2008-04-15
Last Posted Date
2017-05-25
Lead Sponsor
Dana-Farber Cancer Institute
Target Recruit Count
42
Registration Number
NCT00658697
Locations
🇺🇸

University of Maryland - Greenebaum Cancer Center, Baltimore, Maryland, United States

🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy

Phase 2
Active, not recruiting
Conditions
Prostate Cancer
Interventions
First Posted Date
2005-12-22
Last Posted Date
2023-04-18
Lead Sponsor
Medical Research Council
Target Recruit Count
11992
Registration Number
NCT00268476
Locations
🇬🇧

West Suffolk Hospital, Bury St. Edmunds, England, United Kingdom

🇬🇧

Derbyshire Royal Infirmary, Derby, England, United Kingdom

🇬🇧

Russells Hall Hospital, Dudley, England, United Kingdom

and more 115 locations
© Copyright 2025. All Rights Reserved by MedPath